The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study: Shanghai Combizym Clinical Cooperative Group.

Abstract

OBJECTIVE To evaluate the efficacy and safety of Combizym treatment in Chinese patients with dyspepsia. METHODS In this multicenter, randomized, placebo-controlled cross-over study, a total of 151 patients (76 men and 75 women, mean age: 44.67 +/- 6.46 years, range: 22-67 years) with dyspepsia whose symptoms were not relieved by placebos were recruited… (More)
DOI: 10.1111/j.1751-2980.2008.00361.x

Topics

Cite this paper

@article{Ran2009TheEO, title={The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study: Shanghai Combizym Clinical Cooperative Group.}, author={Zhi-hua Ran and Yao Yuan and Z. Li and Jiyao Wang and Chun Hua Zong and Wei Fen Xie and Ping Zheng and Sheng Chen and Xian Zhan and Shi Chen and Shu Dong Xiao}, journal={Journal of digestive diseases}, year={2009}, volume={10 1}, pages={41-8} }